ÂÜÀòÂÒÂ×

Ralph Lambalot, PhD has extensive experience in the field of chemistry, manufacturing, and controls (CMC) in the biopharmaceutical industry. Ralph is currently the Executive Vice President at Neutrolis Inc, a position they have held since 2022. As an executive consultant at Neutrolis Inc, Ralph provided expertise in CMC from 2021 to 2022.

Prior to their current role, Ralph held various leadership positions at AbbVie. From 2013 to 2021, they served as the Vice President of Operations Science & Technology, Biologics, overseeing bioprocess development and commercial lifecycle management of products such as HUMIRA and SKYRIZI. In this role, they led a team of 150+ scientists and engineers.

Before joining AbbVie, Ralph worked at Abbott from 2007 to 2012, where they held multiple positions including Vice President of Operations, Biologics Development & Manufacturing Launch. Ralph was responsible for process development and manufacture of biologics drug substances, managing production facilities across four sites and a total of 530 employees.

Prior to Abbott, Ralph worked at Pfizer from 1999 to 2007, where they held roles such as Director of Protein Biology and Associate Director of Screening Technologies & Materials Management. Ralph was responsible for managing research teams and overseeing protein sciences, structural biology, high-throughput screening, and materials management.

Ralph began their career at BASF in 1996, where they worked as a Senior Research Scientist. Ralph focused on the design and development of protein purification processes for therapeutic protein manufacturing.

Overall, Ralph Lambalot, PhD has extensive experience in CMC, bioprocess development, and manufacturing in the biopharmaceutical industry.

Ralph Lambalot, PhD, has an extensive education history. Ralph began their academic journey at Cornell University, where they pursued a Bachelor of Arts degree in Chemistry. Ralph enrolled in 1983 and successfully completed their undergraduate studies by 1987.

After their undergraduate years, Lambalot continued to delve deeper into their chosen field. Ralph went on to pursue a PhD at Brown University, specializing in Bio-Organic Chemistry. From 1989 to 1994, they dedicated their time to conducting research and expanding their knowledge, ultimately earning their doctorate degree.

Lambalot's thirst for knowledge did not end there, as they aimed to further their expertise through a specialized fellowship. Ralph was granted the opportunity to study at Harvard Medical School from 1994 to 1996, where they engaged in an NIH Post-Doctoral Fellowship focused on Enzymology. This experience allowed him to deepen their understanding of molecular catalysts and their biological implications.

With their educational journey spanning over a decade, Ralph Lambalot, PhD, has demonstrated a strong commitment to expanding their knowledge and expertise in the domains of Chemistry, Bio-Organic Chemistry, and Enzymology.